The Gut Punch Weekly #31

Wegovy beats Zepbound in heart health, Teva launches first generic version of Saxenda, Wegovy gets new FDA approval for liver disease, and more!

Sep 10

August 2025

The Gut Punch Weekly #30

Universal GLP-1 access could save billions, GLP-1 Drugs linked to lower cancer risks, Lilly's oral GLP-1 advances toward FDA approval, and more!

Aug 27

The Gut Punch Weekly #29

Medicare plans trial coverage for obesity drugs, GLP-1 opportunities amid foodtech slump, Novo continues taking L's, Lilly's new oral GLP-1 is pretty…

Aug 13

1

July 2025

The Gut Punch Weekly #28

GLP-1s could become the "everything drug", Novo stock plummets 20%, Trump's tariff on European drugs may raise prices, and more!

Jul 30

The Gut Punch Weekly #27

The hidden protein opportunity, Ozempic may treat addiction cravings, Hengrui's new drug achieves 18% weight loss, Hims is the king of knockoff Ozempic…

Jul 16

The Gut Punch Weekly #26

Lilly's antibody preserves muscle, Novo Nordisk ends Hims deal, China approves first dual GLP-1/GCG obesity drug, and more!

Jul 2

1

June 2025

The Gut Punch Weekly #25

Lilly's Amylin drug shows weight loss with fewer side effects, Novo Nordisk loses Canadian Ozempic patent over unpaid $250 fee, and more!

Jun 18

1

The Gut Punch Weekly #24

GLP-1s elevate eye disease risk, Lilly and Camurus partner on long-acting obesity drugs, GLP-1s linked to unexpected pregnancies, and more!

Jun 11

2

The Gut Punch Weekly #23

Production missteps ended Novo Nordisk's dominance, Regeneron secures $2B deal for Hansoh's obesity drug, Regeneron drug combo preserves muscle mass…

Jun 4

1

May 2025

The Gut Punch Weekly #22

MAHA report calls for broad food & health shakeup, Doctors See Broad Medical Uses for GLP-1s, Wegovy Offers Limited $199 Deal, and more!

May 28

The Gut Punch Weekly #21

Novo's CEO gets the boot, compounders exploit a loophole to keep selling GLP-1 knockoffs, a conversation with the founder of SuperGut, and more!

May 21

The Gut Punch Weekly #20

Trump targets high prices of GLP-1s, Zepbound outperforms Wegovy in weight loss, WeightWatchers files for bankruptcy, weight loss drugs alter taste for…

May 14